Yuhan Corporation (000100) Stock Forecast & Analysis

Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Yuhan Corporation (000100:KRX), powered by AI.

Current Price
₩78,900
P/E Ratio
30.4
Market Cap
6.3T
Sector
Healthcare
What is the Yuhan Corporation stock price forecast?

Yuhan Corporation is currently trading at ₩78,900. View real-time AI analysis on Alpha Lenz.

What is Yuhan Corporation insider trading activity?

View the latest insider trading data for Yuhan Corporation on Alpha Lenz.

What is Yuhan Corporation's P/E ratio?

Yuhan Corporation's P/E ratio is 30.4.

Yuhan Corporation

KRX · 000100
₩78,900+1,700(+2.20%)Market closedKRX regular session 09:00–15:30 KST
Ask about Yuhan Corporation's future dividend policy...
Alpha Chat Insight

Yuhan Corporation trades at a P/E of 30.4 (premium valuation) with solid ROE of 8.8%.

Ask for details

Company Overview

Yuhan Corporation is a prominent entity in the pharmaceutical industry, dedicated to the research, development, and distribution of a wide range of medical products and services. Headquartered in South Korea, Yuhan Corporation is involved in manufacturing prescription drugs, over-the-counter medications, and active pharmaceutical ingredients, supporting both domestic and international markets. In addition to pharmaceuticals, the company also explores biotechnological innovations and manufacturing partnerships to diversify its product offerings. Yuhan Corporation plays a critical role in improving public health by investing in cutting-edge research and fostering collaborations with global pharmaceutical leaders to bring innovative therapies to market. Its comprehensive portfolio addresses various medical needs, influencing sectors from general healthcare to specialized treatments. With a strong emphasis on corporate responsibility and sustainability, Yuhan Corporation prioritizes ethical business practices and environmental stewardship, contributing to its stature as a leading name in the pharmaceutical landscape.

CEO대표이사 조욱제
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
Employees2,038

Company Statistics

FY 2025

Profile

₩6,284,195,718,900Market Cap
₩2,186,637,586,350Revenue
79.65MShares Out
2,038Employees

Margins

33.38%Gross
14.40%EBITDA
4.77%Operating
10.18%Pre-Tax
8.48%Net

Valuation

30.36P/E
2.55P/B
2.69EV/Sales
18.86EV/EBITDA
-153.00P/FCF

Growth (CAGR)

7.18%Rev 3Yr
6.18%Rev 5Yr
42.55%Op Inc 3Yr
4.38%Op Inc 5Yr
26.94%Net Inc 3Yr
-0.54%Net Inc 5Yr

Returns

6.01%ROA
8.81%ROE
7.73%ROIC

Financial Health

₩348,564,938,250Cash & Cash Equivalents
₩510,076,559,980Net Debt
36.35%Debt/Equity
N/AInterest Cov

Frequently Asked Questions

Yuhan Corporation (ticker: 000100) is a company listed on KRX in the Healthcare sector (Drug Manufacturers - Specialty & Generic). It has approximately 2,038 employees. Market cap is $6.3T.

The current price is ₩78,900 with a P/E ratio of 30.36x and P/B of 2.55x.

ROE is 8.81% and operating margin is 4.77%. Annual revenue is $2.2T.

Alpha Lenz
Singapore
Treasurer Pte Ltd | License: 202346277E
9 Straits View Marina One West Tower #05-07 Singapore 018937
contact@treasurer.co.kr
©2026 Treasurer Pte Ltd. All rights reserved.
Yuhan Corporation (000100) Stock Forecast 2026 ₩78,900 — Price, Financials & Analyst Targets | Alpha Lenz